Preventing a Perm with TRPV3  by Montell, Craig
Leading Edge
PreviewsPreventing a Perm with TRPV3
Craig Montell1,*
1Departments of Biological Chemistry and Neuroscience, Center for Sensory Biology, The Johns Hopkins University School of Medicine, 
Baltimore, MD 21205, USA
*Correspondence: cmontell@jhmi.edu
DOI 10.1016/j.cell.2010.03.043
Epidermal growth factor receptor (EGFR) signaling is instrumental for terminal differentiation of kera-
tinocytes, hair morphogenesis, and maintenance of the skin barrier. Cheng et al. (2010) now demon-
strate that the calcium-permeable channel TRPV3 is required for these EGFR-dependent functions.Skin is our first line of defense against 
infection, dehydration, chemical irritants, 
and ultraviolet light. Added protection 
from environmental assaults and thermal 
insulation is provided by hair, a special-
ized type of skin appendage. The outer 
layer of the skin, the epidermis, under-
goes constant renewal regulated by 
signaling through the epidermal growth 
factor receptor (EGFR), which controls 
proliferation and terminal differentiation 
of keratinocytes. As a result, a deficit 
in EGFR signaling has multiple effects, 
including curling of the hair and whis-
kers and impairment of the skin barrier. 
In this issue, Cheng et al. (2010) dem-218 Cell 141, April 16, 2010 ©2010 Elsevier Ionstrate that a member of the transient 
receptor potential (TRP) superfamily of 
cation channels, TRPV3, is present in 
a molecular complex with EGFR and is 
required for late terminal differentiation 
of keratino cytes, hair morphogenesis, 
and skin barrier maintenance.
This discovery builds on prior work 
on waved-1 (wa1) and waved-2 (wa2) 
mouse mutants, known since the 1930s, 
which have curled whiskers and hair—
resembling a perm. This phenotype has 
more recently been shown to result from 
mutations in EGFR and one of its ligands, 
transforming growth factor-α (TGF-α) 
(reviewed in Schneider et al., 2008). nc.Once activated by TGF-α, EGFR couples 
directly or indirectly to several signal-
ing pathways and effectors, such as the 
MAP kinase cascade, phospholipase Cγ 
(PLCγ), PI-3 kinase, and protein kinase 
C. EGFR signaling is also regulated by 
Ca2+-mediated positive feedback. An ini-
tial rise in intracellular Ca2+ activates the 
proteases (sheddases) that release the 
TGF-α (Figure 1A). Thus, engagement 
of the ligand with EGFR leads to a fur-
ther increase in Ca2+, thereby liberating 
more TGF-α and heightening the activity 
of the receptor (Figure 1B). Despite the 
many roles for Ca2+ in EGFR signaling, 
the Ca2+ influx channel(s) that act in this Figure 1. TRPV3 Impacts EGFR Signaling in Hair Morphogenesis
(A and B) Model for positive and negative feedback regulation of epidermal growth factor receptor (EGFR) signaling. (A) Low levels of TRPV3 activity. When 
TRPV3 is constitutively activated at a low level, as might occur at skin temperature, a weak influx of Ca2+ ions leads to low-level activity of tranglutaminase (TG) 
and the metalloprotease ADAM17. ADAM17 releases low levels of TGF-α, which lead to a low level of EGFR activation. Subsequent phosphorylation of TRPV3, 
activation of the kinase ERK, and phospholipase C (PLC), followed by inositol trisphosphate (IP3) production and Ca
2+ release from the endoplasmic reticulum 
(ER), might potentiate TRPV3 activity, as shown in (B). (B) High levels of TRPV3 activation. Strong Ca2+ influx leads to high levels of TG and ADAM17 activity, 
which releases high levels of TGF-α. Induction of high EGFR activity promotes endocytosis and degradation of a fraction of the EGFR pool. 
(C) Mice deficient in trpv3 (trpv3−/−) have curled whiskers and hair, resembling a perm.
pathway in the epidermis were, until now, 
not known. Members of the TRP super-
family of cation channels are intriguing 
candidates given that most are Ca2+ 
permeable and several are expressed 
in skin, and there is a precedent for the 
activation of a TRP channel by a receptor 
tyrosine kinase in cells isolated from the 
brain (Li et al., 1999).
Cheng et al. demonstrate that the 
TRPV3 channel is an integral part of the 
EGFR signaling pathway and is required 
for terminal differentiation of hair, whis-
kers, and the skin barrier. Prior to this 
study, TRPV3 has been shown to be ther-
mally activated by mild warm tempera-
tures that are typical of the skin surface 
and to be expressed in keratinocytes, 
including follicular keratinocytes, which 
are needed for generation and morpho-
genesis of hair and whiskers. Cheng et 
al. produced a “floxed” allele of TRPV3, 
thereby allowing for either global or kera-
tinocyte-specific knockout of the gene. 
All of the mutant animals exhibit curled 
and hooked whiskers and hair reminis-
cent of the wa1 and wa2 phenotypes 
(Figure 1C). The complete penetrance of 
this phenotype is surprising, given that 
hair irregularity only affects subset of 
the previously reported trpv3 knockout 
mice (Moqrich et al., 2005). Cheng et 
al. also find that their knockout mice are 
impaired in terminal differentiation of the 
keratinocytes but not in proliferation of 
the cells in the basal layer.
Of particular importance, the authors 
show that both expression of TGF-α 
and shedding of this ligand depend on 
TRPV3. Consequently, the activity of 
the EGFR receptor is reduced in trpv3 
knockout mice. Conversely, the amount 
of EGFR is increased slightly, presum-
ably due to decreased negative feed-
back of EGFR signaling, which is nor-
mally mediated through endocytosis and 
degradation of the receptor. Given that 
the TRPV3-dependent rise in cytosolic 
Ca2+ is needed for release of the TGF-α 
ectodomain by the metalloprotease 
ADAM17, the question arises as to how 
TRPV3 gets activated prior to engage-
ment of the ligand with the EGFR. The 
authors put forth the intriguing concept 
that skin surface temperature (?32°C) 
induces a relatively low level of TRPV3 
opening (Figure 1A), and that subse-
quent stimulation of the EGFR pathway augments channel activity (Figure 1B). In 
support of this notion, Cheng et al. find 
that that thermal activation of TRPV3 in 
cultured keratinocytes is enhanced by 
stimulation with TGF-α. A future direct 
test of this model in vivo would require 
knocking in a derivative of TRPV3 with 
one of the known mutations in the sixth 
transmembrane that specifically affects 
temperature but not chemical activation 
(Grandl et al., 2008).
Another question concerns the mech-
anism through which activation of TGF-α 
and EGFR enhances TRPV3 activity. The 
answer appears to be complex as inhibi-
tors of either PLC or ERKs (also known as 
MAP kinases) reduce TGF-α potentiation 
of TRPV3 activity. Furthermore, TRPV3 
interacts either directly or indirectly with 
EGFR and is tyrosine phosphorylated, 
which might also contribute to potentia-
tion of TRPV3 activity. There are multiple 
possible modes through which PLCγ 
activity could couple to TRPV3. These 
include production of inositol trispho-
sphate (IP3) and release of Ca
2+ from 
the endoplasmic reticulum—a scenario 
reminiscent of the TrkB/TRPC3 com-
plex in native pontine neurons, which 
leads to activation of TRPC3 through a 
mechanism dependent on IP3 and Ca
2+ 
(Li et al., 1999). It is also an open ques-
tion as to how ERK activity is coupled to 
TRPV3. Although the nuclear functions 
of ERK have received the most attention, 
substrates for this protein kinase include 
cytoskeletal proteins and ion channels 
(Yoon and Seger, 2006). Thus, ERK 
might potentiate TRPV3 either via direct 
phosphorylation or through effects on 
cortical actin.
Among the salient phenotypes of the 
trpv3 knockout mice is impaired skin 
barrier formation. As they proceed on 
their upward journey to the skin sur-
face, keratinocytes ultimately lose their 
nucleus and other organelles and turn 
into flattened corneocytes that line the 
outermost portion of the epidermis. 
In trpv3 knockout mice, the cornified 
envelopes are thinner than in wild-type 
mice. The authors provide a molecular 
mechanism for this deficit by showing 
that the activities of transglutaminases 
(Ca2+-dependent enzymes that crosslink 
proteins to help establish the cell enve-
lope) are impaired in keratinocytes lack-
ing TRPV3.Cell The work by Cheng et al. represents the 
first link between TRPV3 and EGFR signal-
ing. In light of these findings, the previous 
studies on mice expressing a constitu-
tive active allele of TRPV3 also pointed to 
this connection. Surplus EGFR signaling 
in keratinocytes leads to hairless mice, a 
phenotype that is also observed in rodents 
with excessive TRPV3 activity (Asakawa 
et al., 2006; Xiao et al., 2008). Increased 
EGFR signaling in keratinocytes also pro-
motes skin cancer. Although increased 
tumorigenesis has not been described 
in rodents expressing constitutive active 
forms of TRPV3, the study by Cheng et 
al. suggests that this issue deserves 
additional scrutiny. However, given that 
Cheng et al. find that loss of trpv3 does 
not reduce proliferation, in contrast to the 
effect of diminished EGFR signaling, it is 
possible that surplus TRPV3 activity does 
not lead to skin cancer. Nevertheless, it is 
possible that TRPV3 has additional roles 
in the skin, such as in the dermal layer, 
which underlies the epidermis. Carvac-
rol, a known TRPV3 agonist, stimulates a 
Ca2+ rise and collagen expression in der-
mal fibroblasts, and this effect appears 
to require activation of PLCγ and ERK 
(Lee et al., 2008). If collagen expression 
is enhanced by TRPV3, then TRPV3 ago-
nists might represent a new approach for 
boosting collagen levels in skin.
In addition to TRPV3, other TRP chan-
nels, including TRPV1, TRPV4, TRPC6, and 
TRPA1, are expressed in keratinocytes. 
These channels may modulate cell pro-
liferation or act in concert with TRPV3 to 
regulate terminal differentiation in epider-
mis or hair or to help to maintain the skin 
barrier. Given the role of TRPV3 in main-
tenance of the skin barrier, it is possible 
that activators of TRPV3 and other TRPs 
would provide a therapy to treat diseases 
that impair the skin barrier. Consistent with 
this proposal is the recent finding that ago-
nists for TRPA1, including cinnamaldehyde 
and cool temperatures, hasten the recov-
ery following damage to the skin barrier 
(Denda et al., 2010). It would be interesting 
to test whether TRPV3 activators, such as 
camphor, have a similar effect, especially 
in combination with agonists for TRPA1.
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an antiviral response.
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activate downstream signaling kinases, 
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